Pulmonary toxicity due to chemotherapy how is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

Intern Med. 2003 Oct;42(10):926-7. doi: 10.2169/internalmedicine.42.926.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Gefitinib
  • Humans
  • Lung Diseases / chemically induced*
  • Lung Neoplasms / drug therapy*
  • Quinazolines / adverse effects*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib